Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Ploss

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machineryKeith A Berggren, Saloni Sinha, Aaron E Lin, et al.
Science Translational Medicine|June 29, 2018
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infectionBenjamin Y Winer, Elham Shirvani-Dastgerdi, Yaron Bram, et al.
Current HIV Research|December 25, 2019
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID WorkshopRamesh Akkina, Daniel L Barber, Moses T Bility, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Nature|October 30, 2012
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.
The Journal of General Virology|May 17, 2024
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus, Lena Allweiss, Chari Cohen, et al.
Cell|April 23, 2024
Evasion of NKG2D-mediated cytotoxic immunity by sarbecovirusesJordan A Hartmann, Marcella R Cardoso, Maria Cecilia Ramiro Talarico, et al.
Nature|April 24, 2024
Emx2 underlies the development and evolution of marsupial gliding membranesJorge A Moreno, Olga Dudchenko, Charles Y Feigin, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machineryKeith A Berggren, Saloni Sinha, Aaron E Lin, et al.
Science Translational Medicine|June 29, 2018
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infectionBenjamin Y Winer, Elham Shirvani-Dastgerdi, Yaron Bram, et al.
Current HIV Research|December 25, 2019
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID WorkshopRamesh Akkina, Daniel L Barber, Moses T Bility, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Nature|October 30, 2012
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.
The Journal of General Virology|May 17, 2024
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus, Lena Allweiss, Chari Cohen, et al.
Cell|April 23, 2024
Evasion of NKG2D-mediated cytotoxic immunity by sarbecovirusesJordan A Hartmann, Marcella R Cardoso, Maria Cecilia Ramiro Talarico, et al.
Nature|April 24, 2024
Emx2 underlies the development and evolution of marsupial gliding membranesJorge A Moreno, Olga Dudchenko, Charles Y Feigin, et al.
Pageof 17